nmCRPC and Survival with DarolutamideIr al contenidoOncologíaNonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide Fizazi K, et al. N Engl J Med. 2020;383:1040-1049.Contenido relacionadoOS and AEs with darolutamide vs apalutamide vs enzalutamideCPRCnmTreating the patient and not just the cancerCáncer de próstataComparison of darolutamide vs apalutamide and enzalutamideCPRCnm
